Recombinant streptokinase vs phenylephrine-based suppositories in acute hemorrhoids, randomized, controlled trial (THERESA-3)

Table 2 Results of the clinical evaluations after treatment n (%)

	rSK (n = 110)	Phenylephrine (n = 110)	P value
Response after 3 d	41 (37.3)	7 (6.4)	< 0.0011
Response after 5 d (95%CI)3	83 (75.5%; 67.4-83.5)3	36 (32.7%; 24.0-41.5)3	< 0.00113
Difference (95%CI)3	42.7 (30.5-54.2)3
Response after 10 d	92 (83.6)	64 (58.2)	< 0.0011
Days to response: median (95%CI)	5 (4.8-5)	10 (9.8-10)	0.0312

¹Likelihood ratio χ²;

²Log-rank test;

³Main outcome. rSK: Recombinant streptokinase.